{
    "nctId": "NCT00478270",
    "briefTitle": "A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.",
    "officialTitle": "An Open Label Study to Assess the Effect of Intravenous Loading Doses of Bondronat on Metastatic Bone Pain in Patients With Breast Cancer and Skeletal Metastases.",
    "overallStatus": "WITHDRAWN",
    "conditions": "Pain, Bone Neoplasm, Neoplasm Metastasis",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Pain response (20% decrease in mean pain score compared to baseline, and <=50% increase in mean analgesic consumption",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* adult patients, \\>=18 years of age;\n* breast cancer;\n* bone metastases;\n* mean worst pain score \\>=4 during 3 day baseline period;\n* stable dose of analgesics over a 3 day baseline period;\n* adequate renal function.\n\nExclusion Criteria:\n\n* bisphosphonate treatment within 3 weeks of study enrollment;\n* a change in antineoplastic treatment within 6 weeks of study enrollment;\n* bone radiation within 2 weeks of study enrollment;\n* active infection.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}